高级搜索

CD44v6 和MRP 在卵巢癌中的表达

Expression and Signif icance of CD44v6 and MRP in Ovarian Carcinoma

  • 摘要: 目的 探讨CD44v6和MRP在上皮性卵巢癌组织中表达与化疗疗效和预后的关系。方法 采用免疫组织化学S-P法,检测10例正常卵巢组织、20例卵巢良性肿瘤和50例卵巢恶性肿瘤上皮性组织中CD44v6和MRP的表达。结果 ①CD44v6和MRP在卵巢恶性肿瘤中的表达明显高于在良性及正常组织中的表达(P〈0.05);②CD44v6和MRP强阳性率与卵巢癌的临床分期、组织学分级和淋巴结转移有关(P〈0.05);③卵巢癌中CD44v6和MRP的表达呈正相关(r=0.557,P〈0.05);④CD44v6和MRP阳性表达的病例,化疗疗效和预后差。结论 检测卵巢癌中的CD44v6和MRP表达可反映肿瘤细胞的化疗疗效及预测预后。

     

    Abstract: Objective  To study the expression of CD44v6 and MRP in epithelial ovarian carcinoma, and the relationships of expression with the curative effect of chemotherapy and prognosis. Methods  To detect the protein expression of CD44v6 and MRP gene in 10 normal, 20 benign and 50 malignant epithelial ovarian tumor tissue with S-P method of immunohistochemistry technique. Results  ①Positive expression of CD44v6 and MRP in malignant was higher than the expression in benign and normal tissues ( P < 0. 05) .②The staining intensity for CD44v6 and MRP was related to clinical stage, histologic grade and lymphonode metastasis ( P < 0. 05) . ③CD44v6 expression was positive correlated with MRP expression in malignant epithelial ovarian tumors ( r = 0. 557) . ④The cases of the positive rates of CD44v6 and MRP were bad of chemotherapy and poor of prognosis. Conclusion  The detection of CD44v6 and MRP may predict the curative effect of chemotherapy and prognosis in epithelial ovarian carcinoma.

     

/

返回文章
返回